Developer docs
API playgroundTry for free, no card

Search company profiles

Quartesian

Full company profile

uuid000jys2

Namestring
Quartesian
Legal namestring
Quartesian
Websiteurl
quartesian.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Quartesian is a clinical data solutions company that provides Electronic Data Capture (EDC) technology implementation, clinical data management, biostatistics and programming, and medical writing services to biopharmaceutical and medical device sponsors conducting clinical trials. The company's service offering centers on deploying EDC systems — built on over eight years of working experience with Medidata's clinical data technology platform — to capture, clean, validate, and transform trial data into audit-ready datasets, alongside developing standardized global EDC library templates that allow sponsors to standardize clinical data architecture across programs and geographies.

Quartesian sells primarily into two vertical end markets — biopharmaceutical companies running clinical trials and medical device companies preparing regulatory submissions — addressing pain points around legacy process modernization, faster data cleaning, and improved data quality at what the company positions as affordable rates. Its go-to-market is direct enterprise sales executed through project-based professional services engagements, with no public pricing disclosed.

Quartesian was founded and operated as an independent EDC-focused CRO before being acquired by Veranex in 2024. It now operates as a wholly-owned subsidiary under Veranex's 'EDC & Data Solutions' branding, embedded within Veranex's integrated medtech CRO platform that spans trial design, trial management, data management, biostatistics, medical writing, regulatory, quality, and commercialization consulting across medtech categories including cardiovascular, neurology, ophthalmology, and in-vitro diagnostics. The company is headquartered in Newtown, United States, with a flexible global delivery footprint and 101-250 employees.

Short descriptiontext

Quartesian is a clinical data solutions company providing Electronic Data Capture implementation, clinical data management, biostatistics, and medical writing services to biopharmaceutical and medical device sponsors, now operating as the 'EDC & Data Solutions' subsidiary of Veranex.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical data management, electronic data capture, biostatistics services, contract research organization, medical writing services
Industry3 codes
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
Product category
Contract Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Data Solutions Services
TypeProfessional Services
Description

Professional services revenue generated through clinical data management, EDC technology implementation, and clinical data solutions for biopharmaceutical and medical device companies.

veranex.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Quartesian is a clinical data solutions company that delivers Electronic Data Capture (EDC) technology and clinical data management services for clinical trials, including biostatistics, programming, and medical writing. The firm operates as a contract research organization (CRO) with a flexible global footprint, modernizing legacy clinical processes and standardizing clinical data architecture for biopharmaceutical and medical device sponsors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Quartesian is a clinical data solutions company specializing in Electronic Data Capture (EDC) technology and clinical data management services. The company offers a unified platform for EDC with associated data management and biostatistics services. Quartesian's core offering centers on EDC technology that bridges the gap between legacy clinical processes and digital environments, providing clean data faster to improve analysis speed and data quality while developing global EDC library standards. The company operated for over eight years with Medidata clinical data technology solutions before being acquired by Veranex.

Product and service4 records
1Electronic Data Capture (EDC) Services
CategoryClinical Data Technology Services
Description

Implementation and operation of EDC technology for clinical trials, including upgrading legacy clinical processes to modern EDC platforms. Targeted at biopharmaceutical and medical device sponsors running clinical studies.

2Clinical Data Management Services
CategoryClinical Research Services
Description

End-to-end clinical data management for clinical trials, producing clean, standardized clinical data architecture. Targeted at clinical trial sponsors in biopharma and medical device industries.

3Biostatistics & Programming Services
CategoryClinical Research Services
Description

Biostatistics and programming support for clinical trials, including analysis datasets, statistical outputs, and regulatory-grade deliverables. Targeted at clinical trial sponsors requiring statistical analysis.

4Medical Writing Services
CategoryClinical Research Services
Description

Medical writing support for clinical study reports, regulatory submissions, and related clinical documentation. Targeted at biopharmaceutical and medical device sponsors preparing regulatory filings.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Quartesian worked with Medidata clinical data technology solutions for over eight years, building expertise in EDC technology implementation and clinical data management using Medidata's platform. This partnership enabled Quartesian to deliver high quality clinical data solutions to biopharmaceutical and medical device clients.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medidata is the leading EDC platform provider whose Rave Clinical Cloud forms the backbone of most modern clinical trials. Quartesian has built 8+ years of Medidata implementation expertise, making Medidata the closest upstream/peer technology provider competing for sponsor mind share on clinical data capture.

TypeDirect peer
Description

Veeva's CDB (Clinical Data Base) and Vault EDC platform competes directly with Medidata Rave in the clinical data capture market. As Quartesian services Medidata-based trials, Veeva represents the alternative EDC ecosystem where similar data management and biostatistics services are demanded.

3Oracle Health Sciences (Clinical One)
TypeBroad incumbent
Description

Oracle's Clinical One platform and broader Health Sciences suite provide EDC, clinical data management, and analytics for trial sponsors, overlapping with Quartesian's core offerings. Oracle is a broader incumbent serving pharma and CROs with both platform and analytics layers.

TypeDirect peer
Description

Signant Health specializes in clinical trial technology services including EDC implementation, data management, and biostatistics for pharma and medical device sponsors. Directly comparable niche CRO/service provider focused on clinical data capture and trial enablement.

TypeEmerging player
Description

ArisGlobal provides life sciences R&D platforms including clinical trial management and safety solutions. Its platform competes in adjacent clinical data and trial enablement where Quartesian's EDC and biostatistics services operate.

TypeBroad incumbent
Description

Parexel is a top-5 global CRO offering full clinical trial services including biostatistics, data management, and medical writing for pharma/biotech. Represents the broader incumbent against which Quartesian competes as a focused data-management specialist.

TypeBroad incumbent
Description

IQVIA is the largest global CRO with extensive in-house biostatistics, data management, and EDC services. As a broad incumbent with proprietary technology platforms, IQVIA competes with Quartesian for outsourced clinical data work.

TypeDirect peer
Description

Bioforum is a specialized CRO focused on clinical data management, biostatistics, and EDC implementation—essentially a direct competitive mirror of Quartesian's offering. Comparable size and scope make it one of the closest specialized peers.

TypeBroad incumbent
Description

Worldwide Clinical Trials is a mid-sized global CRO offering clinical data management, biostatistics, and trial execution services. Provides broader-scope competition for Quartesian's specialized data services.

TypeDirect peer
Description

Celerion is a CRO specializing in early-phase clinical research including clinical data management and biostatistics services. Comparable niche-focused CRO competing for outsourced biopharmaceutical data work.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quartesian

Contract Research Organization (CRO) Servicesquartesian.com

Quartesian is a clinical data solutions company providing Electronic Data Capture implementation, clinical data management, biostatistics, and medical writing services to biopharmaceutical and medical device sponsors, now operating as the 'EDC & Data Solutions' subsidiary of Veranex.

What Quartesian does

Quartesian is a clinical data solutions company that provides Electronic Data Capture (EDC) technology implementation, clinical data management, biostatistics and programming, and medical writing services to biopharmaceutical and medical device sponsors conducting clinical trials. The company's service offering centers on deploying EDC systems — built on over eight years of working experience with Medidata's clinical data technology platform — to capture, clean, validate, and transform trial data into audit-ready datasets, alongside developing standardized global EDC library templates that allow sponsors to standardize clinical data architecture across programs and geographies.

Quartesian sells primarily into two vertical end markets — biopharmaceutical companies running clinical trials and medical device companies preparing regulatory submissions — addressing pain points around legacy process modernization, faster data cleaning, and improved data quality at what the company positions as affordable rates. Its go-to-market is direct enterprise sales executed through project-based professional services engagements, with no public pricing disclosed.

Quartesian was founded and operated as an independent EDC-focused CRO before being acquired by Veranex in 2024. It now operates as a wholly-owned subsidiary under Veranex's 'EDC & Data Solutions' branding, embedded within Veranex's integrated medtech CRO platform that spans trial design, trial management, data management, biostatistics, medical writing, regulatory, quality, and commercialization consulting across medtech categories including cardiovascular, neurology, ophthalmology, and in-vitro diagnostics. The company is headquartered in Newtown, United States, with a flexible global delivery footprint and 101-250 employees.

Quartesian firmographics

Firmographics
Name
Quartesian
Legal name
Quartesian
Website
https://quartesian.com
Company type
Private
Founded year
2003
Operating status
Acquired
Headcount range
101–250 employees
Short description
Quartesian is a clinical data solutions company providing Electronic Data Capture implementation, clinical data management, biostatistics, and medical writing services to biopharmaceutical and medical device sponsors, now operating as the 'EDC & Data Solutions' subsidiary of Veranex.
Ownership category
akta.pro rank

Quartesian industry classification

Industry
Product category
Contract Research Organization (CRO) Services
akta.pro industry
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Clinical data management
  • Electronic data capture
  • Biostatistics services
  • Contract research organization
  • Medical writing services

Where Quartesian is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Markets served

Quartesian business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Clinical Data Solutions Services: Professional services revenue generated through clinical data management, EDC technology implementation, and clinical data solutions for biopharmaceutical and medical device companies.

Go-to-market motion1 record

Distribution channels1 record

Quartesian product offering

Product offering

Core offering

Quartesian is a clinical data solutions company that delivers Electronic Data Capture (EDC) technology and clinical data management services for clinical trials, including biostatistics, programming, and medical writing. The firm operates as a contract research organization (CRO) with a flexible global footprint, modernizing legacy clinical processes and standardizing clinical data architecture for biopharmaceutical and medical device sponsors.

Product overview

Quartesian is a clinical data solutions company specializing in Electronic Data Capture (EDC) technology and clinical data management services. The company offers a unified platform for EDC with associated data management and biostatistics services. Quartesian's core offering centers on EDC technology that bridges the gap between legacy clinical processes and digital environments, providing clean data faster to improve analysis speed and data quality while developing global EDC library standards. The company operated for over eight years with Medidata clinical data technology solutions before being acquired by Veranex.

Differentiator

Problem solved

Functional benefit

Products and services

  • Electronic Data Capture (EDC) Services Implementation and operation of EDC technology for clinical trials, including upgrading legacy clinical processes to modern EDC platforms. Targeted at biopharmaceutical and medical device sponsors running clinical studies.
  • Clinical Data Management Services End-to-end clinical data management for clinical trials, producing clean, standardized clinical data architecture. Targeted at clinical trial sponsors in biopharma and medical device industries.
  • Biostatistics & Programming Services Biostatistics and programming support for clinical trials, including analysis datasets, statistical outputs, and regulatory-grade deliverables. Targeted at clinical trial sponsors requiring statistical analysis.
  • Medical Writing Services Medical writing support for clinical study reports, regulatory submissions, and related clinical documentation. Targeted at biopharmaceutical and medical device sponsors preparing regulatory filings.

Companies that use Quartesian

Customer profile

Segments2 records

Ideal customer profiles1 record

Quartesian technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Quartesian partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MedidatacoreTechnology or IntegrationQuartesian worked with Medidata clinical data technology solutions for over eight years, building expertise in EDC technology implementation and clinical data management using Medidata's platform. This partnership enabled Quartesian to deliver high quality clinical data solutions to biopharmaceutical and medical device clients.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Quartesian competitors and assessment

Company assessment

Direct peers

  • Medidata Solutions (Dassault Systèmes): Medidata is the leading EDC platform provider whose Rave Clinical Cloud forms the backbone of most modern clinical trials. Quartesian has built 8+ years of Medidata implementation expertise, making Medidata the closest upstream/peer technology provider competing for sponsor mind share on clinical data capture.
  • Veeva Systems: Veeva's CDB (Clinical Data Base) and Vault EDC platform competes directly with Medidata Rave in the clinical data capture market. As Quartesian services Medidata-based trials, Veeva represents the alternative EDC ecosystem where similar data management and biostatistics services are demanded.
  • Signant Health (formerly CRF Bracket / Bioclinica): Signant Health specializes in clinical trial technology services including EDC implementation, data management, and biostatistics for pharma and medical device sponsors. Directly comparable niche CRO/service provider focused on clinical data capture and trial enablement.
  • Bioforum Bio-Médical-Audit SARL: Bioforum is a specialized CRO focused on clinical data management, biostatistics, and EDC implementation—essentially a direct competitive mirror of Quartesian's offering. Comparable size and scope make it one of the closest specialized peers.
  • Celerion: Celerion is a CRO specializing in early-phase clinical research including clinical data management and biostatistics services. Comparable niche-focused CRO competing for outsourced biopharmaceutical data work.

Broad incumbents

  • Oracle Health Sciences (Clinical One): Oracle's Clinical One platform and broader Health Sciences suite provide EDC, clinical data management, and analytics for trial sponsors, overlapping with Quartesian's core offerings. Oracle is a broader incumbent serving pharma and CROs with both platform and analytics layers.
  • Parexel International: Parexel is a top-5 global CRO offering full clinical trial services including biostatistics, data management, and medical writing for pharma/biotech. Represents the broader incumbent against which Quartesian competes as a focused data-management specialist.
  • IQVIA: IQVIA is the largest global CRO with extensive in-house biostatistics, data management, and EDC services. As a broad incumbent with proprietary technology platforms, IQVIA competes with Quartesian for outsourced clinical data work.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering clinical data management, biostatistics, and trial execution services. Provides broader-scope competition for Quartesian's specialized data services.

Emerging players

  • ArisGlobal: ArisGlobal provides life sciences R&D platforms including clinical trial management and safety solutions. Its platform competes in adjacent clinical data and trial enablement where Quartesian's EDC and biostatistics services operate.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Quartesian social profiles

Digital presence

Quartesian financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quartesian leadership team

Management profile

Number of profiles

Profiles2 records

Quartesian funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quartesian M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quartesian

What does Quartesian do?

Quartesian is a clinical data solutions company that delivers Electronic Data Capture (EDC) technology and clinical data management services for clinical trials, including biostatistics, programming, and medical writing. The firm operates as a contract research organization (CRO) with a flexible global footprint, modernizing legacy clinical processes and standardizing clinical data architecture for biopharmaceutical and medical device sponsors.

Is Quartesian a public or private company?

Quartesian is a private company. It is classified as corporate owned and is currently acquired.

When was Quartesian founded?

Quartesian was founded in 2003. It employs 101 to 250 people.

Where is Quartesian based?

Quartesian is headquartered in Princeton, United States, in the North America region.

How does Quartesian make money?

One revenue line is on record: clinical Data Solutions Services.

Who are Quartesian's main competitors?

Direct peers on record are Medidata Solutions (Dassault Systèmes), Veeva Systems, Signant Health (formerly CRF Bracket / Bioclinica), Bioforum Bio-Médical-Audit SARL and Celerion. Broad incumbents are Oracle Health Sciences (Clinical One), Parexel International, IQVIA and Worldwide Clinical Trials. ArisGlobal is listed as an emerging player.

Does Quartesian have an API?

No public API is recorded for Quartesian.

What industry is Quartesian in?

Quartesian's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicaldesignandoutsourcingXimedica, Quartesian, Boston Healthcare Associates combine into VeranexPrivate equity firm Summit Partners has acquired Ximedica, Quartesian, and Boston Healthcare Associates to form a new medtech service company named Veranex. The Raleigh-based entity positions itself as the first concept-to-commercialization global service provider in the medtech sector, offering integrated design, regulatory, and market access capabilities. Veranex plans to pursue organic growth and further acquisitions to expand its platform and help clients accelerate time to market.PR NewswireQuartesian Surpasses 250 Studies Employing Medrio's EDC PlatformQuartesian, a multinational clinical research organization serving the biopharmaceutical and medical device industries, announced that it has deployed Medrio's cloud-based Electronic Data Capture platform across 265 clinical studies worldwide, surpassing the 250-study milestone in their partnership that began in 2009. The collaboration combines Medrio's Direct Data Capture and ePRO capabilities with Quartesian's therapeutic expertise and data visualization services to improve clinical trial efficiency and remote monitoring. Medrio's CEO stated that the partnership is helping drive data-driven insights for clinical teams and advancing progress toward medical breakthroughs.AiThorityQuartesian Signs Global Medical Technology Company to Multi-Year Clinical Data Management Services AgreementQuartesian signed a multi-year agreement with a medical technology company to provide EDC programming, data management, and SAS statistical services. The services support several franchises and aim to modernize the client's clinical data architecture. The company highlights its eight-year Medidata experience and global footprint.PR NewswireQuartesian Signs Global Medical Technology Company to Multi-Year Clinical Data Management Services AgreementQuartesian, a multinational Clinical Research Organization serving the biopharmaceutical and medical device industries, has signed a multi-year agreement with a leading portfolio medical technology company to provide clinical data management services. Under the agreement, Quartesian is providing Electronic Data Capture programming using Medidata Rave EDC, full data management, and SAS statistical services to support several product franchises. The engagement involves transitioning the client from multiple legacy processes to a standardized modern EDC architecture to improve data quality and speed up analysis.PR NewswireQuartesian Extends Growth Record in 2020Quartesian, a multinational Clinical Research Organization serving the biopharmaceutical and medical device industries, announced record revenue and increased contracts for 2020, marking its 18th consecutive year of profitability despite challenges in the clinical trial environment. Key financial highlights included 27% annual revenue growth, 32% pipeline growth, and 28% bookings expansion compared to 2019, while the company added 45 new clients and grew its workforce to over 525 employees. The company stated that improved profitability and operating cash flows position 2021 as a significant value-creating year.PR NewswireQuartesian Achieves ISO 9001:2015 and ISO/IEC 27001:2013 certificationsQuartesian, a multinational Clinical Research Organization headquartered in Princeton, New Jersey, announced it has earned ISO 9001:2015 certification for quality management and ISO/IEC 27001:2013 certification for information security from Bureau Veritas Certification Holding SAS – UK Branch. The certifications, awarded on December 7 and December 15, 2020 respectively, followed audits of the company's operations including locations in Bengaluru and Kolkata, India. The company stated the certifications demonstrate its commitment to quality service and security during the COVID-19 pandemic while operating remotely.PR NewswireQuartesian Announces Amyndas Partnership for COVID-19 Clinical TrialQuartesian, a multinational Clinical Research Organization, announced a partnership with Amyndas Pharmaceuticals to support a Phase 2 clinical trial evaluating AMY-101, a complement inhibitor, in COVID-19 patients with acute respiratory distress syndrome (ARDS). Quartesian will provide EDC technology, Data Management, Biostats, Pharmacovigilance, and Medical Writing services for the trial. The CEO stated the study represents an important step in understanding C3 complement inhibitors for COVID-19 treatment.PR NewswireQuartesian Announces Veeva Partnership for Clinical Data ManagementQuartesian, a multinational clinical research organization, announced its membership in Veeva's new partner program to build clinical studies using Veeva Vault EDC. The company is the first Veeva partner to complete training for Vault EDC and has already started five studies for oncology and medical device customers, with several more in the pipeline. This partnership enables Quartesian to collaborate with sponsors during the build process and reduce study database build time through real-time case report form changes.